Xenon Pharmaceuticals Inc. (XENE) Social Stream
XENON PHARMACEUTICALS INC (XENE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering XENON PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-28 | 8 | $50 | $34 | $44.857 | $47.15 | -4.86% |
| 2022-01-23 | 7 | $50 | $40 | $45.857 | $47.15 | -2.74% |
| 2022-03-02 | 8 | $50 | $40 | $45.857 | $47.15 | -2.74% |
| 2022-06-22 | 8 | $50 | $40 | $46 | $47.15 | -2.44% |
| 2022-07-21 | 9 | $60 | $40 | $47.625 | $47.15 | 1.01% |
| 2022-08-10 | 9 | $60 | $40 | $49 | $47.15 | 3.92% |
| 2022-08-11 | 9 | $60 | $46 | $50.75 | $47.15 | 7.64% |
| 2022-09-17 | 9 | $60 | $46 | $50.75 | $47.15 | 7.64% |
| 2022-10-13 | 9 | $60 | $46 | $51.125 | $47.15 | 8.43% |
| 2022-10-19 | 10 | $60 | $46 | $51.222 | $47.15 | 8.64% |
| 2022-11-09 | 10 | $60 | $35 | $49.333 | $47.15 | 4.63% |
| 2022-11-11 | 11 | $60 | $46 | $50.4 | $47.15 | 6.89% |
| 2022-11-14 | 11 | $60 | $46 | $50.2 | $47.15 | 6.47% |
| 2022-11-28 | 12 | $60 | $46 | $50.181 | $47.15 | 6.43% |
| 2023-01-03 | 14 | $60 | $46 | $51 | $47.15 | 8.17% |
| 2023-01-26 | 14 | $60 | $46 | $51.166 | $47.15 | 8.52% |
| 2023-02-08 | 14 | $60 | $46 | $51.333 | $47.15 | 8.87% |
| 2023-03-02 | 15 | $60 | $44 | $51.153 | $47.15 | 8.49% |
| 2023-04-20 | 15 | $60 | $44 | $51.307 | $47.15 | 8.82% |
| 2023-04-25 | 15 | $60 | $44 | $51.384 | $47.15 | 8.98% |
| 2023-05-10 | 16 | $60 | $46 | $52.428 | $47.15 | 11.19% |
| 2023-06-06 | 15 | $60 | $46 | $52.5 | $47.15 | 11.35% |
| 2023-08-10 | 16 | $60 | $46 | $52.5 | $47.15 | 11.35% |
| 2023-10-08 | 16 | $60 | $46 | $52.642 | $47.15 | 11.65% |
| 2023-11-09 | 16 | $60 | $46 | $52.416 | $47.15 | 11.17% |
| 2023-11-27 | 16 | $60 | $46 | $52.166 | $47.15 | 10.64% |
| 2023-11-28 | 15 | $60 | $46 | $52.791 | $47.15 | 11.96% |
| 2023-12-01 | 16 | $60 | $46 | $52.791 | $47.15 | 11.96% |
| 2023-12-08 | 17 | $63 | $46 | $53.576 | $47.15 | 13.63% |
| 2023-12-19 | 17 | $63 | $46 | $54.653 | $47.15 | 15.91% |
The Trend in the Analyst Price Target
Over the past 43 months, XENE's average price target has gone up $30.44.
XENE reports an average of 41.45% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-23 | 14 | 60 | 46 | 51.166 | 36.15 | 41.54% |
| 2023-04-25 | 15 | 60 | 44 | 51.384 | 39.77 | 29.2% |
| 2023-11-09 | 16 | 60 | 46 | 52.153 | 30.00 | 73.84% |
| 2023-11-15 | 16 | 60 | 46 | 52.166 | 29.15 | 78.96% |
| 2023-11-28 | 15 | 60 | 46 | 52.791 | 35.24 | 49.8% |
XENE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.18 | 14 | 3 | 0 | 0 | 0 | 17 |
The Trend in the Broker Recommendations
Over the past 31 weeks, XENE's average broker recommendation rating improved by 0.01.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, XENON PHARMACEUTICALS INC's variance in analysts' estimates is lower than -478.27% of them.
- In terms of how XENON PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 3105.4% of that group.
- In terms of how XENON PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 704.4% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, XENON PHARMACEUTICALS INC's average analyst price target is greater than 2630.75% of them.
In the Pharmaceutical Products industry, CMRX, NKTX, and ALXO are the three stocks most similar to XENON PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding XENE using the data that counts. Try POWR Ratings for free.